News | February 18, 2009

GE Installs First Series of Discovery PET/CT 600 Series Scanners

February 18, 2009 – GE Healthcare said the new Discovery PET/CT 600-series scanners, designed to help enable earlier detection and accurate monitoring of disease, are being installed globally.

The first clinical installs will be completed at: Miami Baptist Hospital in Florida; University Hospital of Bichat in Paris, France; Queensland X-Ray at the Mater Hospital in Brisbane, Australia; Duke University Medical Center in North Carolina; and Mayo Clinic in Minnesota.

The new PET/CT platform was built based on clinician needs for more power to explore the potential of PET/CT imaging that includes better PET quantitative accuracy, according to GE. This new line of PET/CT scanners, combine advanced molecular imaging tools with the large coverage low dose Volume CT helping allow for earlier diagnosis, more accurate tumor location and better assessment of how a patient is responding to cancer treatment. Although mostly for use in oncology, PET/CT can also be used for assisting the diagnosis of cardiovascular disease and neurological conditions.

The new system leverages the high-speed, high-resolution capabilities of GE’s advanced CT, the LightSpeed VCT. Volume CT technology, with 40 mm of coverage, reduces CT acquisition times and CT dose. Static organs can be imaged in as little as one second, the lung in as little as two seconds and a whole body trauma could be performed in less than 10 seconds.

GE's next generation of MotionFree imaging technologies are introduced in the new Discovery 600 series PET/CT, giving clinicians detailed images even in areas of the body subject to movement caused by respiration. GE's MotionFree imaging technologies are integrated with VUE Point FX, an advanced high-definition reconstruction technique. Combined, these technologies have the potential to improve small lesion detection, image quality, and better therapy response monitoring.

By combining the LightSpeed VCT with the breakthrough motion management capabilities of the Discovery PET system, the new Discovery PET/CT platform provides the next evolution PET/CT system, bringing clinically-relevant innovations designed to open doors to new and advanced procedure possibilities in non-invasive diagnostic imaging.

For more information: www.gehealthcare.com

Related Content

Rupa Sanghani, M.D., FASNC, director of Rush's nuclear cardiology and stress laboratory, explaining to ASNC 2019 attendees how Rush implemented its program during a tour of its PET-CT suite.

Rupa Sanghani, M.D., FASNC, director of Rush's nuclear cardiology and stress laboratory, explaining to ASNC 2019 attendees how Rush implemented its program during a tour of its PET-CT suite.
 

Feature | PET-CT | February 19, 2020 | Dave Fornell, Editor
As hospital imaging departments look to replace aging nuclear scanners with updated technology, many are asking if...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Nuclear myocardial perfusion scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers. The image shows good clarity with delineation of the left ventricular edge and papillary muscles without cardiac gating.

Nuclear myocardial perfusion scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers. The image shows good clarity with delineation of the left ventricular edge and papillary muscles without cardiac gating.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT | July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
PET/CT, calcium blockages, heart attack risk, Intermountain study, American Heart Association, AHA Scientific Sessions 2016
News | PET-CT | November 15, 2016
Many people who experience chest pain but don’t have a heart attack breathe a big sigh of relief when a stress test...
PET/CT, atherosclerotic plaque detection, Stanford University

Application of dual-modality optical and PET/CT activity-based probe in experimental carotid inflammation model. Coronal noninvasive PET/CT scans of (A) healthy and (B) diseased mice with and without ligated carotid arteries respectively. Inset images show optical ex vivo florescence imagining of (A) healthy and (B) diseased carotid arteries.  PET/CT and optical images courtesy of Xiaowei Ma, Toshinobu Saito and Nimali Withana.

News | PET-CT | November 01, 2016
Researchers at Stanford University have demonstrated for the first time the use of a dual optical and positron emission...